Synexus strides forward with "pioneering" patient recruitment model
Synexus has been making business strides of late, thanks to its "innovative" model for patient recruitment and monitoring for late stage clinical trials.
Synexus has been making business strides of late, thanks to its "innovative" model for patient recruitment and monitoring for late stage clinical trials.
An artificial self-assembling virus capable of serving as a drug delivery system has been created by researchers in Korea, according to a publication in Angewandte Chemie.
Pharmaceutical manufacturers are now withdrawing from manufacturing at an unprecedented rate, with four of the top 10 players announcing major new outsourcing programmes in 2007, says IMS in a new document which explores the implications of that trend.
A pump-powered nebulizer for delivering vaccinations in the developing world is being worked on by researchers at Aerovax, at the Massachusetts Institute of Technology (MIT).
Michigan-based drugmaker Perrigo and Cobrek Pharmaceuticals, a newly formed subsidiary of Pentech Pharmaceuticals, are teaming up to develop a range of topical generic products for the dermatology sector.
Irish drugmaker Elan is considering a separate stock exchange listing for its contract services unit, Elan Drug Technology, according to comments by executives at its recent annual general meeting.